300181 Zhejiang Jolly Pharmaceutical
- 16.65
- -0.34-2.00%
Zhejiang Jolly Pharmaceutical News
Zuoli Pharmaceutical: Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders
Zuoli Pharmaceutical: Announcement on signing a strategic cooperation framework agreement with Lingyi (Hangzhou) Biotechnology Co., Ltd.
Zuoli Pharmaceutical: Legal Opinion of Shanghai Oriental Huayin Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Zhejiang Zuoli Pharmaceutical Co., Ltd.
Zuli Pharmaceuticals: 2024 Employee Stock Ownership Plan
Zuli Pharmaceuticals: 2024 Employee Stock Ownership Plan (Draft) Summary
Zuli Pharmaceutical: 2024 Employee Stock Ownership Plan (Draft)
Zuoli Pharmaceutical: Announcement on the Notice of Convening the First Extraordinary General Meeting of Shareholders in 2024
Zuoli Pharmaceuticals: Prompt Announcement for Disclosure of Report for the Third Quarter of 2024
Zuoli Pharmaceutical: Announcement on the “Double Improvement of Quality and Return” action plan
Zhejiang Jolly Pharmaceutical: Zhejiang Jolly Pharmaceutical Co., Ltd.'s summary table of non-operational fund utilization and other related fund transactions for the first half of 2024.
Zhejiang Jolly Pharmaceutical: Interim report disclosure prompt announcement for 2024.
Zhejiang Jolly Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Zhejiang Jolly Pharmaceutical: Announcement on the completion of the election of the Board of Directors and the Board of Supervisors and the appointment of senior managers, heads of audit departments, and representatives of securities affairs
Zhejiang Jolly Pharmaceutical: Legal Opinion of Shanghai Oriental Huayin Law Firm on the 2023 Annual General Meeting of Shareholders of Zhejiang Zuoli Pharmaceutical Co., Ltd.
Zhejiang Jolly Pharmaceutical: Notice on the company's senior management receiving the Zhejiang Securities Regulatory Bureau's regulatory dialogue measures decision
Zuoli Pharmaceutical: 2023 Internal Control Self-Assessment Report
Zuoli Pharmaceutical: Working System for Special Meetings of Independent Directors
Zuoli Pharmaceutical: Announcement on the Notice of Convening the 2023 Annual General Meeting of Shareholders
Zuoli Pharmaceutical: Special note by the board of directors on the retroactive adjustment of financial statements
Zuoli Pharmaceutical: Report of the Audit Committee of the Board of Directors on the evaluation of the performance of accounting firms in 2023 and the performance of supervisory duties
No Data
